Abstract
This chapter outlines a regulator’s personal approach to the assessment of reproductive toxicology data in the context of the assessment of the overall nonclinical data package for pharmaceutical agents. Using as a framework the International Conference on Harmonisation Common Technical Document headings, guidance is provided on the expectations of regulators for the presentation and discussion of the data by the applicant to facilitate the risk assessment process. Consideration is given to the use of reproductive toxicology data in the assessment process for both clinical trial applications (CTAs) and marketing authorization applications (MAAs). Suggestions for some guiding principles in drafting of the various product information documents (for example the Investigator’s Brochure (IB) for CTAs and the Nonclinical Overview and Summary of Product Characteristics for MAAs) are included.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Dorato MA, Engelhardt JA (2005) The no-observed-adverse-effect-level in drug safety evaluation: use, issues, and definition(s). Regul Toxicol Pharmacol 42:265–274
Wise LD et al (2008) Assessment of female and male fertility in Sprague-Dawley rats administered vorinostat, a histone deacetylase inhibitor. Birth Defects Res B Dev Reprod Toxicol 83(1):19–26
Dickinson BD et al (2001) Drug interactions between oral contraceptives and antibiotics. Obstet Gynecol 98:853–860
Nau HJ (2001) Teratogenicity of isotretinoin revisited: species variation and the role of all-trans-retinoic acid. J Am Acad Dermatol 45(5):S183–S187
Mittendorf R (1995) Teratogen update: carcinogenesis and teratogenesis associated with exposure to diethylstilbestrol (DES) in utero. Teratology 51(6):435–445
Chahoud I et al (1999) Classification terms in developmental toxicology: need for harmonisation. Reprod Toxicol 13:77–82
Paumgartten F et al (2009) Harmonization of terminology in developmental toxicology: the quest for a more precise description and a harmonized classification of fetal observations. Reprod Toxicol 27:8–13
Galderma limited, Meridien House, 69-71 Clarendon Road, Watford, Hertfordshire, WD17 1DS, UK Summary of Product Characteristics for Differin Cream. Electronic Medicines Compendium. http://www.medicines.org.uk/emc/medicine/691/SmPC/Differin+Cream/
Khera KS (1985) Maternal toxicity: a possible etiological factor in embryo-fetal deaths and fetal malformations of rodent-rabbit species. Teratology 31:129–153
International conference on harmonisation of technical requirements for registration of pharmaceuticals for human use (2005) ICH harmonised tripartite guideline, Detection of toxicity to reproduction for medicinal products & toxicity to male fertility, S5(r2) current step 4 version parent guideline dated 24 June 1993 (addendum dated 9 November 2000 incorporated in November 2005)
Barlow SM, Morrison PJ, Sullivan FM (1975) Effects of acute and chronic stress on plasma corticosterone levels in the pregnant and non-pregnant mouse. J Endocrinol 66:93–99
Cappon GD et al (2005) Effects of feed restriction during organogenesis on embryo-fetal development in rabbit. Birth Defects Res B Dev Reprod Toxicol 74:424–430
Fleeman TL et al (2005) Effects of feed restriction during organogenesis on embryo-fetal development in the rat. Birth Defects Res B Dev Reprod Toxicol 74:442–449
Brennan FR, Dougan G (2005) Non-clinical safety evaluation of novel vaccines and adjuvants: new products, new strategies. Vaccine 23:3210–3222
Acknowledgment
The author would like to thank JW McBlane for his helpful comments on the manuscript.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer Science+Business Media, LLC
About this protocol
Cite this protocol
Davidson, E. (2013). Regulatory Assessment of Reproductive Toxicology Data. In: Barrow, P. (eds) Teratogenicity Testing. Methods in Molecular Biology, vol 947. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-62703-131-8_33
Download citation
DOI: https://doi.org/10.1007/978-1-62703-131-8_33
Published:
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-62703-130-1
Online ISBN: 978-1-62703-131-8
eBook Packages: Springer Protocols